Neurocrine Biosciences Inc
LSE:0K6R
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neurocrine Biosciences Inc
LSE:0K6R
|
US |
|
I
|
Indian Metals and Ferro Alloys Ltd
BSE:533047
|
IN |
|
S
|
Steppe Cement Ltd
XBER:ST9
|
MY |
|
A
|
Advanced Micro Devices Inc
XETRA:AMD
|
US |
|
E
|
EROAD Ltd
OTC:ERDLF
|
NZ |
|
N
|
NOW Inc
SWB:11N
|
US |
|
Linea Directa Aseguradora SA Compania de Seguros y Reaseguros
OTC:LNDAF
|
ES |
|
Z
|
Zoetis Inc
SWB:ZOE
|
US |
|
C
|
CSPC Pharmaceutical Group Ltd
XMUN:CVG
|
CN |
|
ACS Actividades de Construccion y Servicios SA
OTC:ACSAY
|
ES |
|
Andritz AG
OTC:ADRZF
|
AT |
|
Kajima Corp
TSE:1812
|
JP |
Wall St Price Targets
0K6R Price Targets Summary
Neurocrine Biosciences Inc
According to Wall Street analysts, the average 1-year price target for 0K6R is 197.3 USD with a low forecast of 147.53 USD and a high forecast of 262.02 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0K6R's stock price target?
Price Target
197.3
USD
According to Wall Street analysts, the average 1-year price target for 0K6R is 197.3 USD with a low forecast of 147.53 USD and a high forecast of 262.02 USD.
What is the Revenue forecast for Neurocrine Biosciences Inc?
Projected CAGR
19%
Over the last 13 years, the compound annual growth rate for Revenue has been 36%. The projected CAGR for the next 3 years is 19%.
What is the Gross Profit forecast for Neurocrine Biosciences Inc?
Projected CAGR
20%
The compound annual growth rate for Gross Profit over the next 3 years is 20%.
What is the Operating Income forecast for Neurocrine Biosciences Inc?
Projected CAGR
41%
Over the last 13 years, the compound annual growth rate for Operating Income has been 53%. The projected CAGR for the next 3 years is 41%.
What is the Pre-Tax Income forecast for Neurocrine Biosciences Inc?
Projected CAGR
38%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 46%. The projected CAGR for the next 3 years is 38%.
What is the Net Income forecast for Neurocrine Biosciences Inc?
Projected CAGR
40%
Over the last 13 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 3 years is 40%.
